SILO PHARMA, INC. Investment Income, Interest
SILO PHARMA, INC. (SILO) reported Investment Income, Interest of $1.34 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- SILO PHARMA, INC. investment income, interest for the quarter ending 2026-06-30 was $1.15K.
- SILO PHARMA, INC. investment income, interest for the quarter ending 2026-03-31 was $191.00.
- SILO PHARMA, INC. investment income, interest for the quarter ending 2018-09-30 was $18.00, a 99.72% decline year-over-year.
- SILO PHARMA, INC. investment income, interest for the quarter ending 2017-09-30 was $6.50K.
- SILO PHARMA, INC. investment income, interest for fiscal 2013 was $625.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.34K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $191.00 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $207.00 POS AM · filed 2026-04-14 | |||
| 2018-09-30 | $18.00 10-Q · filed 2018-11-14 | $44.00 10-Q · filed 2018-11-14 | ||
| 2017-09-30 | $6.50K 10-Q · filed 2018-11-14 | $20.48K 10-Q · filed 2018-11-14 | ||
| 2013-12-31 | $625.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |